Indoco Remedies informs about disclosure

17 Dec 2024 Evaluate
Indoco Remedies has informed that further to the notification dated October 11, 2024, for receipt of Official Action Indicated (OAI) status from the USFDA for Plant II & Plant III facility located at Goa (Facility), subsequently the Facility has received a warning letter from USFDA on December 17, 2024. This Facility was inspected from July 16, 2024 to July 26, 2024. 

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

211.80 -2.35 (-1.10%)
20-Jan-2026 12:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.80
Dr. Reddys Lab 1184.20
Cipla 1380.55
Zydus Lifesciences 876.15
Lupin 2167.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×